These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 8839956

  • 1. Neuroleptic malignant syndrome and risperidone: a case report.
    Bonwick RJ, Hopwood MJ, Morris PL.
    Aust N Z J Psychiatry; 1996 Jun; 30(3):419-21. PubMed ID: 8839956
    [Abstract] [Full Text] [Related]

  • 2. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
    Robb AS, Chang W, Lee HK, Cook MS.
    J Child Adolesc Psychopharmacol; 2000 Jun; 10(4):327-30. PubMed ID: 11191694
    [Abstract] [Full Text] [Related]

  • 3. High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
    Dursun SM, Oluboka OJ, Devarajan S, Kutcher SP.
    J Psychopharmacol; 1998 Jun; 12(2):220-1. PubMed ID: 9694035
    [Abstract] [Full Text] [Related]

  • 4. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
    Newman M, Adityanjee, Jampala C.
    Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
    [No Abstract] [Full Text] [Related]

  • 5. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S, Buckley P.
    Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
    [Abstract] [Full Text] [Related]

  • 6. Neuroleptic malignant syndrome associated with risperidone long-acting injection: a case report.
    Yamashita T, Fujii Y, Misawa F.
    J Clin Psychopharmacol; 2013 Feb; 33(1):127-9. PubMed ID: 23288234
    [No Abstract] [Full Text] [Related]

  • 7. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C, Planès S, Logerot S, Villier C, Mallaret M.
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptic Malignant Syndrome After Early Administration of Risperidone Long-Acting Injection.
    Mitchell BG, McMahon BC, Mitchell CW.
    Prim Care Companion CNS Disord; 2017 Nov 30; 19(6):. PubMed ID: 29195036
    [No Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
    Chungh DS, Kim BN, Cho SC.
    J Psychopharmacol; 2005 Jul 30; 19(4):422-5. PubMed ID: 15982999
    [Abstract] [Full Text] [Related]

  • 10. Lamotrigine-induced neuroleptic malignant syndrome under risperidone treatment: a case report.
    Motomura E, Tanii H, Usami A, Ohoyama K, Nakagawa M, Okada M.
    J Neuropsychiatry Clin Neurosci; 2012 Jul 30; 24(2):E38-9. PubMed ID: 22772697
    [No Abstract] [Full Text] [Related]

  • 11. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A, Baeza I, Morer A, Lázaro ML, Bernardo M.
    J Child Adolesc Psychopharmacol; 2005 Dec 30; 15(6):844-5. PubMed ID: 16379503
    [No Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M, Altavista MC, Cavallari S, Lubich L.
    Eur Arch Psychiatry Clin Neurosci; 1994 Dec 30; 243(6):299-303. PubMed ID: 7913834
    [Abstract] [Full Text] [Related]

  • 13. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB.
    Can J Psychiatry; 1996 Feb 30; 41(1):52-4. PubMed ID: 8919425
    [Abstract] [Full Text] [Related]

  • 14. Neuroleptic malignant syndrome associated with use of risperidone, ritonavir, and indinavir: a case report.
    Lee SI, Klesmer J, Hirsch BE.
    Psychosomatics; 2000 Feb 30; 41(5):453-4. PubMed ID: 11015640
    [No Abstract] [Full Text] [Related]

  • 15. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
    Kosehasanogullari SG, Akdede B, Akvardar Y, Akan M, Tunca Z.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1147-8. PubMed ID: 17513032
    [No Abstract] [Full Text] [Related]

  • 16. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H, Aizenberg D, Weizman A, Lapidot M, Mayor C, Munitz H.
    Br J Psychiatry; 1992 Aug 30; 161():254-7. PubMed ID: 1355693
    [Abstract] [Full Text] [Related]

  • 17. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O, Kurtz G, Müller-Felber W, Modell S.
    Nervenarzt; 1994 Oct 30; 65(10):718-21. PubMed ID: 7808573
    [Abstract] [Full Text] [Related]

  • 18. Encephalopathy with combined lithium-risperidone administration.
    Boora K, Xu J, Hyatt J.
    Acta Psychiatr Scand; 2008 May 30; 117(5):394-5; discussion 396. PubMed ID: 18331580
    [Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A, Schumacher J, Abdalla E, LePage J, McGhee M, Butcher D, Griffin H, Shahda M.
    W V Med J; 2002 May 30; 98(2):63-5. PubMed ID: 12048741
    [Abstract] [Full Text] [Related]

  • 20. [Neuroleptic malignant syndrome. Case reports].
    Berardi D, Troia M, Veronesi L, Ferrari G.
    Minerva Psichiatr; 1994 Dec 30; 35(4):199-219. PubMed ID: 7861943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.